phentodur phentermine (as hydrochloride) 30 mg modified release capsule blister pack
arrotex pharmaceuticals pty ltd - phentermine hydrochloride, quantity: 37.332 mg - capsule, modified release - excipient ingredients: gelatin; liquid paraffin; magnesium stearate; titanium dioxide; sodium polystyrene sulfonate; iron oxide red; lactose monohydrate; iron oxide black; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - phentermine is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater. the treatment with phentermine can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.
phentodur phentermine (as hydrochloride) 15 mg modified release capsule blister pack
arrotex pharmaceuticals pty ltd - phentermine hydrochloride, quantity: 18.666 mg - capsule, modified release - excipient ingredients: gelatin; sodium polystyrene sulfonate; iron oxide black; lactose monohydrate; brilliant blue fcf; titanium dioxide; magnesium stearate; iron oxide yellow; liquid paraffin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - phentermine is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater. the treatment with phentermine can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.
vancomycin hcl injection 500 mgvial
zyfas pharma pte ltd - vancomycin hcl eqv vancomycin - injection, powder, for solution - vancomycin hcl eqv vancomycin 500 mg/vial
purist table - table, operation, <specify>
pureplay orthopaedics -
35393 - table, operation,
syringe, dental, irrigating
healthware aus pty ltd - 35970 - syringe, dental, irrigating - the monoject syringe is a non-sterile, plastic and rubber device used for irrigation of solutions.
cannulated surgical drill guiding pin
pureplay orthopaedics - 62058 - cannulated surgical drill guiding pin - surgical drill tip guide wire, for transient use, to assist surgical placement of graft anchors/screws in soft tissue surgery. this item is single use.
suture retention device
pureplay orthopaedics - 33519 - suture retention device - the parcus actiflip is indicated for use in the fixation of ligaments and tendons in patients requiring ligament or tendon repair. the actiflip is represented in different sizes, with sutures attached
soft-tissue anchor, non-bioabsorbable
pureplay orthopaedics - 45062 - soft-tissue anchor, non-bioabsorbable - adjustable suture construct with two titanium buttons. the oblong shaped button spans a drilled tunnel for medial cortex fixation and a titanium ?top hat? shaped button for lateral cortex fixation. creating stability in the ankle joint
surgical drill, fluted, single-use
pureplay orthopaedics - 47563 - surgical drill, fluted, single-use - fluted surgical drill single use
cannulated surgical drill, single-use
pureplay orthopaedics - 61235 - cannulated surgical drill, single-use - cannulated surgical drill bit single use sterile